Coalition urges DHS to broaden access to opioid overdose reversal drugs
Wisconsin should change its policies to boost access to all opioid overdose reversal drugs allowed by the Food and Drug Administration, a coalition urged the Department of Health Services last week.
To access this content, you must purchase a Premium membership, or log in if you are a member.
